Table 11.6h

Persistency of Discharge Regimen by Follow-up Period, 2001 to 2005

			Year of Transplant
			2001	2002	2003	2004	2005
Discharge Regimen (w/ or w/o Steroid Use)	CyA+Aza	At Discharge (N)	206	139	94	84	49
		At Discharge (%)	100.0%	100.0%	100.0%	100.0%	100.0%
		1 Year PostTx (%)	48.3%	39.0%	45.2%	63.1%	71.7%
		2 Years PostTx (%)	27.3%	32.3%	34.6%	40.5%	35.9%
		3 Years PostTx (%)	22.5%	25.0%	29.4%	40.5%	-
	CyA+MMF	At Discharge (N)	1,036	838	827	750	636
		At Discharge (%)	100.0%	100.0%	100.0%	100.0%	100.0%
		1 Year PostTx (%)	73.7%	67.3%	67.5%	77.9%	83.1%
		2 Years PostTx (%)	55.9%	53.0%	55.1%	62.2%	72.3%
		3 Years PostTx (%)	48.6%	45.6%	47.1%	48.8%	-
	CyA+Siro	At Discharge (N)	3	19	39	2	2
		At Discharge (%)	100.0%	100.0%	100.0%	100.0%	100.0%
		1 Year PostTx (%)	66.7%	63.2%	51.3%	50.0%	100.0%
		2 Years PostTx (%)	0.0%	57.9%	38.5%	50.0%	-
		3 Years PostTx (%)	0.0%	47.4%	33.0%	-	-
	Siro+MMF	At Discharge (N)	4	7	19	24	16
		At Discharge (%)	100.0%	100.0%	100.0%	100.0%	100.0%
		1 Year PostTx (%)	25.0%	28.6%	63.2%	75.0%	68.2%
		2 Years PostTx (%)	25.0%	28.6%	52.6%	46.9%	-
		3 Years PostTx (%)	25.0%	28.6%	42.1%	-	-
	Tac+Aza	At Discharge (N)	27	27	26	23	19
		At Discharge (%)	100.0%	100.0%	100.0%	100.0%	100.0%
		1 Year PostTx (%)	51.9%	40.7%	60.0%	78.3%	51.7%
		2 Years PostTx (%)	37.0%	37.0%	38.8%	65.7%	51.7%
		3 Years PostTx (%)	25.9%	25.9%	19.4%	-	-
	Tac+MMF	At Discharge (N)	390	483	571	720	941
		At Discharge (%)	100.0%	100.0%	100.0%	100.0%	100.0%
		1 Year PostTx (%)	75.7%	75.4%	76.8%	83.8%	85.9%
		2 Years PostTx (%)	62.2%	62.8%	68.3%	73.0%	72.5%
		3 Years PostTx (%)	56.4%	55.0%	62.1%	68.0%	-
	Tac+Siro	At Discharge (N)	47	111	36	19	23
		At Discharge (%)	100.0%	100.0%	100.0%	100.0%	100.0%
		1 Year PostTx (%)	61.7%	65.5%	66.7%	55.7%	78.4%
		2 Years PostTx (%)	46.4%	55.5%	60.3%	47.8%	39.2%
		3 Years PostTx (%)	41.5%	47.2%	51.0%	-	-